Facebook Twitter RSS Feed

You are here

News

 - unhappy doctor

When choosing a device-based treatment for patients with peripheral artery disease, physicians may find themselves in a quandary. A cost-effectiveness model found that the best deal from a payer’s perspective was the worst option for the provider, according to a presentation Sept. 13 at the Transcatheter Cardiovascular Therapeutics scientific session.

 - pills

Unfractionated heparin-vitamin K antagonist combination was found to be the least effective of venous thromboembolism treatments in a meta-analysis published online Sept. 17 in JAMA while some novel oral anticoagulants carried lower bleeding risks.

 - futuristic

If surgeons want to remain relevant in cardiology, they had better be open to change, warned the co-director of a high-volume transcatheter aortic valve replacement center at the Transcatheter Cardiovascular Therapeutics scientific session.

 - angry physician

If you want your cath lab to run efficiently and safely, you need a director with clear vision and the ability to take charge, even—make that especially— in times of strife, a physician leader said Sept. 13 at the Transcatheter Cardiovascular Therapeutics scientific session.

 - Female Physician

Women are a minority in interventional cardiology, but they are taking on more complex procedures in urban settings and experiencing a high level of procedural success. Cindy L. Grines, MD, presented these findings Sept. 14 at the Transcatheter Cardiovascular Therapeutics conference.